Clinical Guides
Head and Neck Cancer — Recognition, Staging and Management
A clinically focused guide to recognising and staging upper aerodigestive tract cancers and coordinating function-preserving multidisciplinary care in India, with explicit limits on applying foreign referral and treatment pathways.
MedNext Academy | 14 min read
Head and Neck Cancer — Recognition, Staging and Management
A clinically focused guide to recognising and staging upper aerodigestive tract cancers and coordinating function-preserving multidisciplinary care in India, with explicit limits on applying foreign referral and treatment pathways.
Summary
Head and neck cancer is not one disease. This guide focuses on malignancies of the oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, nasal cavity and paranasal sinuses, most of which are squamous cell carcinomas. Site, subsite, stage, human papillomavirus association in the oropharynx, Epstein–Barr virus association in the nasopharynx, pathology and baseline function affect prognosis and treatment. Thyroid cancer, skin cancer, primary brain tumours, sarcoma, lymphoma, paediatric disease and many salivary cancers require separate pathways and should not be forced into a generic squamous-cancer algorithm.
Warning presentations include an oral ulcer lasting more than three weeks, an indurated oral lesion, erythroplakia, persistent hoarseness, progressive swallowing difficulty, referred ear pain with normal otoscopy, unilateral nasal obstruction or blood-stained discharge, trismus, cranial neuropathy and an unexplained persistent neck node. Adult cystic neck masses must not be assumed benign. Airway compromise, major bleeding, severe aspiration and treatment-related neutropenic sepsis are emergencies. Diagnosis requires complete examination of mucosal sites and neck, endoscopy where indicated, imaging and tissue; destructive open biopsy of a neck node can compromise later treatment planning.
Management is multidisciplinary and often combines surgery, radiotherapy and systemic therapy. The aim is oncological control while preserving breathing, speech, swallowing, nutrition, appearance and social participation. Dental preparation, speech and swallowing assessment, nutrition, tobacco and areca-nut cessation, rehabilitation and psychosocial care begin before treatment. This guide is educational: it cannot select a radiation plan, neck dissection, reconstructive procedure or systemic regimen. Indian specialist protocols and patient priorities govern every decision.
How Common Is It?
Head and neck cancers collectively carry major importance in India, particularly cancers of the lip and oral cavity. The IARC India fact sheet ranks cancer sites using modelled national estimates and shows oral-cavity disease among the country's leading incident cancers, with a substantial male burden. The category is not identical to all head and neck cancer: it does not automatically include larynx, pharynx, nasal sinus, salivary gland or thyroid sites. Numbers from different publications cannot be added unless site definitions, sex, age standardisation and year match.
Indian patterns differ from many high-income settings because smokeless tobacco and areca-nut products contribute heavily alongside smoked tobacco and alcohol. HPV-associated oropharyngeal cancer is biologically distinct and its relative contribution varies across populations and laboratories. Nasopharyngeal cancer has regional and ethnic clustering, while sinonasal and salivary malignancies remain uncommon. Changing tobacco use, vaccination, age structure, diagnostic access and registry coverage can alter observed trends. A national estimate does not describe every state, tribal population, rural district or referral centre.
Population survival varies sharply by site and stage. An early lip lesion, an HPV-associated oropharyngeal cancer and an advanced hypopharyngeal cancer cannot share one prognosis. Delayed presentation, malnutrition, nodal burden, extranodal extension, treatment interruption and limited rehabilitation worsen outcomes. Published survival from foreign registries also reflects their staging edition, treatment access and competing mortality. Clinicians should use the confirmed subsite, pathology, TNM stage and individual fitness for counselling. Burden statistics justify prevention and early diagnosis; they do not prove that every mouth ulcer or hoarse voice is malignant.
Risk Factors
Smoked and smokeless tobacco are central preventable causes, and combined alcohol exposure can multiply risk for squamous cancers of the oral cavity, pharynx and larynx. In India, chewing products may contain tobacco, areca nut, slaked lime and flavouring; composition and frequency should be documented without euphemism. Areca nut is carcinogenic even when tobacco is absent. Reverse smoking and chronic exposure patterns matter in some communities. Risk falls after cessation but does not immediately return to baseline, and continuing exposure also raises treatment complications and second-primary risk. Counselling should be specific, respectful and linked to pharmacological or behavioural support.
Persistent high-risk HPV infection drives a subset of oropharyngeal cancers, especially tonsil and tongue-base disease. HPV status is a tumour biomarker with staging implications, not evidence of recent infidelity or a reason to stigmatise the patient. Epstein–Barr virus is associated with nasopharyngeal carcinoma. Additional associations include poor oral health, occupational wood or leather dust for selected sinonasal cancers, prior radiation, immunosuppression and certain inherited disorders. Sun exposure relates to external lip cancer, while salivary tumours have different and less defined risks.
Risk evaluation must not become diagnostic exclusion. People who never used tobacco can develop head and neck cancer, and common exposure does not prove a lesion is malignant. Ask about treatment vulnerability: dental status, hearing, renal function, neuropathy, aspiration, weight loss, airway symptoms, frailty and previous radiotherapy. Social risks include inability to stop work, transport costs, low health literacy, dependence on a substance-using household and fear of disfigurement. These can interrupt a long radiotherapy course and should be addressed before the first fraction rather than blamed afterward.
Diagnosis
History
Define the precise subsite and duration of ulcer, lump, red or white patch, pain, bleeding, loose tooth, trismus, dysarthria, dysphagia, odynophagia, aspiration, voice change, nasal obstruction, epistaxis, hearing change and neck swelling. Ask about unilateral otalgia with normal ear findings, weight loss, fever, night sweats and cranial symptoms. Record tobacco in every form, areca nut, alcohol, occupational dust, prior cancer or radiation, dental procedures, sexual history only when clinically relevant and sensitively obtained, and family history.
Examination
Assess stridor, work of breathing, secretion control, bleeding, hydration and nutrition first. Inspect and palpate lips, buccal mucosa, gingiva, tongue including ventral and lateral surfaces, floor of mouth, palate and accessible oropharynx. Note lesion dimensions, induration, fixation, depth clues, tooth involvement and trismus. Palpate neck systematically by level, including bilateral nodes, thyroid and salivary glands. Examine cranial nerves, skin, ears and nasal cavity. Flexible nasendoscopy belongs in trained hands.
Investigations
Obtain tissue from the primary or a suspicious node using a route planned with the head and neck team. Ultrasound-guided fine-needle aspiration or core biopsy is preferred for many neck masses; avoid unplanned open node biopsy. Contrast CT or MRI maps the primary and nodes according to site. Chest CT or PET-CT is selected for systemic staging; current guidelines supports PET-CT in specific advanced or occult-primary settings. Pathology should report type, grade, margins and relevant biomarkers, including validated p16 testing for oropharyngeal squamous carcinoma. Baseline dental imaging, blood tests, renal, thyroid, hearing, nutrition and swallowing assessments support treatment safety.
Differential Diagnosis
Aphthous ulceration, trauma from a sharp tooth or denture, thermal injury and viral ulcers are common oral mimics. A traumatic label should improve after the cause is removed; persistence, induration, bleeding or a three-week duration requires reassessment. Oral candidiasis, tuberculosis, syphilis and deep fungal infection can ulcerate, especially with immunosuppression, but infection should be demonstrated rather than used to postpone biopsy. Oral lichen planus, leukoplakia, erythroplakia and submucous fibrosis are potentially malignant disorders with different transformation risks and surveillance needs. Dental abscess and osteomyelitis may produce pain, swelling or nodes.
Persistent hoarseness may reflect reflux-related irritation, vocal overuse, benign nodules, polyps, paralysis, chronic laryngitis or neurological disease. Unilateral nasal obstruction or bleeding can arise from polyps, infection, juvenile angiofibroma or inflammatory disease. Neck masses include reactive lymphadenopathy, tuberculosis, lymphoma, branchial anomalies, salivary lesions, thyroid nodules and metastatic cancer from below the clavicle. In an adult, a new lateral cystic node may be an HPV-associated oropharyngeal metastasis and must not be excised as a branchial cyst without oncological evaluation.
Histological differentials include squamous carcinoma, salivary carcinoma, lymphoma, melanoma, sarcoma and metastasis. Nasopharyngeal carcinoma and sinonasal malignancies have site-specific patterns. A neck node with squamous carcinoma and no visible primary requires systematic occult-primary evaluation, not a vague unknown cancer label. The purpose of differential diagnosis is to choose safe tissue and imaging, protect the airway and avoid delay. A short antibiotic course is reasonable only for a credible infection with documented review; repeated courses for a persistent node are unsafe.
Management
Every confirmed cancer should be discussed by a head and neck multidisciplinary team including site-appropriate surgery, radiation oncology, medical oncology, radiology, pathology, restorative dentistry, nutrition, speech and swallowing, specialist nursing and rehabilitation. Before definitive treatment, record TNM stage, pathology and biomarkers, airway, dental disease, hearing, renal function, nutrition, speech, swallow and performance status. The team should explain cure probability, functional effects, appearance, feeding and airway options, fertility where relevant and the consequences of interruption. Patient preference follows a balanced account of alternatives, not a single-specialty recommendation.
Early oral-cavity cancers are commonly treated surgically with adequate margins and neck management based on occult nodal risk. Early laryngeal cancers may be treated with transoral surgery or radiotherapy according to site, voice outcome and expertise. More advanced disease may require composite resection, neck dissection and microvascular reconstruction, or organ-preservation chemoradiotherapy in selected sites. Postoperative radiotherapy or chemoradiotherapy depends on pathological risk such as margins and extranodal extension. HPV positivity improves prognosis in many oropharyngeal cancers but treatment de-intensification should remain within validated protocols or trials.
Recurrent or metastatic disease requires assessment for salvage surgery or re-irradiation, systemic therapy, trial enrolment and symptom-focused care. Airway protection, haemorrhage planning, analgesia, nutrition, aspiration management and communication support remain active treatments. Dental clearance and preventive care reduce radiation complications; prophylactic removal of healthy teeth without restorative assessment is not appropriate. Speech and swallow exercises, shoulder rehabilitation after neck dissection, trismus prevention, stoma care and psychosocial support start early. Surveillance seeks recurrence, second primaries and late effects while continuing cessation support and thyroid, dental, hearing and nutritional review.
Prescribing Information
Systemic anticancer treatment and concurrent radiosensitisation require specialist protocols. Platinum compounds, fluoropyrimidines, taxanes, targeted EGFR therapy and immune-checkpoint inhibitors may be used in different curative, recurrent or metastatic contexts. A drug name alone is not a recommendation: subsite, stage, pathology, p16 or viral context, PD-L1 testing when indicated, prior therapy, treatment intent, performance status and current Indian regulatory or institutional policy determine selection. Carboplatin is not an automatic interchangeable substitute for cisplatin, and cetuximab should not be assumed equivalent to cisplatin-based chemoradiation.
Before treatment, verify blood counts, renal and hepatic function, electrolytes including magnesium, hearing, neuropathy, hydration, dental status, infection, nutrition, pregnancy possibility and medicines that affect kidneys, bleeding or QT interval. Cisplatin can cause renal injury, hearing loss, neuropathy and severe nausea; hydration and monitoring are protocol-defined. Fluoropyrimidines can cause mucositis, diarrhoea, marrow suppression and cardiotoxicity, with pretreatment enzyme or pharmacogenomic policy varying by jurisdiction. Immunotherapy may cause inflammatory toxicity affecting nearly any organ and needs a distinct escalation pathway, not reflex steroids without oncology advice.
Supportive prescribing is equally safety-critical. Radiation mucositis often requires scheduled analgesia, oral care, topical measures and nutrition support; febrile neutropenia, aspiration infection and candidiasis must be distinguished. Opioids need bowel and sedation plans. Enteral feeding route and timing should follow swallowing and MDT assessment. Do not prescribe antibiotics repeatedly for a tumour, or vitamins and antioxidants as substitutes for treatment. Tobacco-dependence medicines should be offered where suitable. Exact doses, radiation schedules, antiemetic combinations and feeding formulas are deliberately absent because they require patient-specific, current local protocols.
When to Refer
Refer an unexplained oral ulcer lasting more than three weeks, an oral or lip lump, erythroplakia or erythroleukoplakia, persistent unexplained hoarseness, progressive dysphagia, unilateral otalgia with normal otoscopy, cranial neuropathy or a persistent unexplained neck mass to an appropriate head and neck or oral-cancer service. current guidelines uses a suspected-cancer pathway for persistent unexplained neck lumps or oral ulceration over three weeks and for persistent unexplained hoarseness in people aged 45 or over. These thresholds organise UK services; they are not Indian national law and should not delay referral of a younger high-risk or clinically suspicious patient.
Urgent dental assessment can help with an oral lesion, but referral must reach a service capable of biopsy and cancer management. A suspicious adult neck node should be evaluated with head and neck examination, imaging and planned needle sampling rather than open excision. Referral documentation should include lesion site, measurements and duration, images if consented, node levels, airway and swallowing status, weight, exposures, dental findings, prior antibiotics, pathology, imaging, renal and hearing status, comorbidity and barriers to attendance. Send actual scans and slides when possible.
Refer early to dietetics, restorative dentistry, speech and swallowing therapy and tobacco or areca-nut cessation. Genetics is selective for unusual age, tumour type or family history. After treatment, new pain, ulceration, neck mass, voice or swallow deterioration, bleeding, weight loss, cranial deficit or pulmonary symptom needs prompt recurrence or second-primary assessment. Normal initial imaging does not end evaluation of a persistently suspicious mucosal lesion. Safety-net with an explicit review date and named destination rather than telling the patient to return only if it worsens.
Red Flags
Stridor, increasing work of breathing, inability to handle secretions, rapidly worsening tongue or floor-of-mouth swelling, severe aspiration or falling oxygen saturation requires emergency airway assessment by experienced anaesthesia and head and neck teams. Agitation or fatigue may precede collapse. Avoid repeated blind airway attempts through a distorted tumour. Active major oral or neck bleeding, sentinel bleeds from an irradiated wound, expanding neck swelling or haemodynamic instability can precede catastrophic carotid haemorrhage and demand resuscitation, haemorrhage protocol activation and urgent surgical or interventional-radiology input.
Fever, hypotension, confusion or rigors during systemic therapy may be neutropenic sepsis even without impressive local signs. Severe mucositis with inability to drink, reduced urine, uncontrolled pain or electrolyte disturbance needs urgent assessment. New chest symptoms, choking, wet voice or recurrent fever may represent aspiration. Sudden unilateral neck swelling, facial oedema, pleuritic pain or dyspnoea raises thrombosis or pulmonary embolism. After surgery, a chyle leak, fistula, flap colour or temperature change, wound bleeding or airway obstruction requires direct contact with the treating unit.
Progressive cranial neuropathy, trismus, orbital symptoms, severe referred otalgia, vertebral pain or rapidly enlarging nodes can signal advanced local disease. Osteoradionecrosis may present with exposed bone, pain, infection or fracture; dental extraction in an irradiated field needs specialist planning. Late airway stenosis, hypothyroidism, carotid disease and swallowing impairment are clinically important even years after cure. A persistent oral lesion should not be repeatedly cauterised or treated with topical steroid without diagnosis, and an adult cystic node should never be reassured solely because it looks benign on ultrasound.
Indian Clinical Context
India's prevention priorities must include smoked tobacco, smokeless tobacco and areca nut in all commercial and homemade forms. Asking only whether a patient smokes misses major exposure. Cessation advice should identify the exact product, dependence and household context and connect to available behavioural and pharmacological support. Visual oral examination can support early detection in trained programmes, but a screening encounter is useful only when a suspicious lesion reaches biopsy and treatment. A negative opportunistic examination cannot protect a person from later symptoms, and self-examination campaigns must not shift responsibility away from accessible services.
Access to endoscopy, expert pathology, p16 testing, PET-CT, intensity-modulated radiotherapy, microvascular reconstruction, dental rehabilitation and speech therapy varies widely. Treatment plans should preserve oncological quality while acknowledging travel, accommodation, time away from work and nutrition. Interrupted radiotherapy can compromise outcome, so barriers should be anticipated. Central review of slides or scans can prevent repeat procedures. Public or charitable funding and state pathways change; teams must verify eligibility rather than promise free care.
current guidelines and NG36 are UK guidance with UK referral ages, service structures and technology assumptions. NCI material is a US evidence synthesis. Neither is an Indian prescribing, radiation or reimbursement rule. This guide states those limitations instead of disguising foreign recommendations as universal. Indian institutional protocols, current approvals, facility expertise and patient preference govern treatment. Cultural sensitivity is particularly important for speech, facial change, sexuality, substance exposure and family participation. Consent belongs to the patient; family involvement is supported when the patient wishes, not used to withhold diagnosis or control decisions.
NMC Competency Mapping
The NMC CBME 2024 curriculum gives exact core outcomes for the main scope of this guide. Surgery competency SU20.1 addresses the etiopathogenesis, symptoms and signs of oral and oropharyngeal cancer; SU20.2 covers appropriate investigations and principles of treatment. Pathology competency PA23.1 addresses the aetiology, pathogenesis, pathology and clinical features of oral cancers. These competencies integrate with oral and ENT examination, neck anatomy, radiology, pharmacology and community prevention. They do not authorise an undergraduate to biopsy an unsafe neck mass, plan radiation, perform neck dissection or prescribe systemic anticancer therapy.
A graduating learner should inspect the entire accessible oral cavity with light and gloves, recognise an indurated ulcer, erythroplakia, leukoplakia, submucous fibrosis, trismus, persistent hoarseness and a suspicious adult neck node, and examine nodes by anatomical level. They should elicit tobacco, smokeless tobacco, areca nut and alcohol exposure without judgement; distinguish HPV-associated oropharyngeal disease from a behavioural accusation; and identify airway or bleeding emergencies. They should understand the roles of endoscopy, contrast CT or MRI, ultrasound-guided node sampling, histology, p16 and systemic staging.
Clinical reasoning should connect subsite to lymphatic drainage, TNM stage, treatment modality and functional consequence. Learners must explain why unplanned open-node biopsy is harmful, why a three-week oral ulcer needs referral, and why nutrition, dental care, speech and swallow rehabilitation are part of cancer management. Professional competencies include consent for examination, privacy, clear safety-netting, tobacco and areca-nut cessation, disclosure of uncertainty, and coordination across Indian care levels. Examination proficiency is not specialist independence; suspected disease should move promptly to the appropriate team.
Key Exam Pearls for NEET PG
Oral squamous carcinoma commonly involves the lateral tongue and floor of mouth; an indurated non-healing ulcer, erythroplakia and unexplained tooth mobility are warning signs. Submucous fibrosis is strongly associated with areca nut and causes progressive trismus. Tobacco and alcohol have synergistic risk for many upper aerodigestive squamous cancers. HPV-associated oropharyngeal carcinoma often arises in tonsil or tongue base, may present as a cystic neck node, and uses p16 as a validated surrogate in the appropriate pathology context. EBV is linked to nasopharyngeal carcinoma, which can present with cervical nodes, nasal symptoms or unilateral middle-ear effusion.
Persistent hoarseness suggests laryngeal disease, while referred otalgia with normal otoscopy can arise from pharyngeal or laryngeal pathology. Supraglottic tumours have rich lymphatic drainage and present with nodes more often than early glottic cancers. Bilateral drainage matters for midline tongue-base, supraglottic and nasopharyngeal sites. A hard fixed node suggests metastasis, but tuberculosis and lymphoma remain important Indian differentials. Do not perform an unplanned open biopsy of an adult neck node before imaging, mucosal evaluation and needle sampling.
Early disease may use one definitive modality; advanced disease often combines surgery and adjuvant treatment or organ-preservation chemoradiation. Positive margins and extranodal extension are major adverse pathological features. Radiotherapy complications include mucositis, xerostomia, dental caries, dysphagia, hypothyroidism, trismus and osteoradionecrosis. Neck dissection can impair shoulder function through accessory-nerve injury. Airway obstruction and tumour haemorrhage override routine staging. In exam stems, identify subsite first, then node drainage, tissue method, stage principle and functional trade-off; never assume all head and neck cancers share one pathway.
Frequently Asked Questions
Does every white patch in the mouth mean oral cancer?
No. Friction, candidiasis, inflammatory disease and other benign conditions can appear white. A persistent non-scrapable patch, especially with red change, induration, ulceration or high-risk exposure, needs trained assessment and sometimes biopsy because clinical appearance alone cannot reliably determine dysplasia. Persistence after an apparent irritant is removed requires review.
Why should an adult neck lump not simply be removed first?
A neck lump can be a metastatic node from a small occult mucosal cancer. Unplanned open excision may disrupt tissue planes, complicate staging and affect definitive neck treatment. Complete head and neck assessment, imaging and planned ultrasound-guided needle sampling usually provide a safer diagnostic route.
Is HPV-associated throat cancer proof of recent sexual exposure?
No. HPV-related oropharyngeal cancer can occur many years after infection, and tumour p16 status cannot establish when or from whom infection was acquired. Results should be explained without blame. The biomarker informs classification and prognosis but does not justify unvalidated treatment de-intensification.
Can radiotherapy cure head and neck cancer without affecting swallowing?
Radiotherapy can be curative for selected sites and stages, but dose to tumour and nearby structures may cause mucositis, dry mouth, taste change, fibrosis and swallowing impairment. Modern planning, dental preparation, nutrition and swallowing exercises reduce harm but cannot promise normal function.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic